With the focus on improving patient experience
and reducing burden on sites
PHILADELPHIA, June 26, 2024 /PRNewswire/ -- Suvoda LLC, a
global clinical trial technology company that specializes in
complex studies in therapeutic areas like oncology, central nervous
system (CNS), and rare diseases, announced the early adopter launch
of its ePatient product. This innovative solution is designed to
address the complexities, inefficiencies, and frustrations patients
encounter with stipend and reimbursement payments, as well as
appointment management, throughout their clinical trial
journey.
ePatient is set to transform the patient experience by unifying
payments, appointments, reminders, and eCOA questionnaires into a
single user-friendly mobile interface with the simple, intuitive
design Suvoda is known for. The application's seamless integration
with Suvoda's IRT and eConsent ensures a cohesive user experience,
enabling site users and patients to move effortlessly between all
Suvoda products with a single sign-on.
"By listening to the needs of our customers and leveraging our
expertise in clinical trial technology, we have created a solution
that not only improves the patient experience but also enhances
operational efficiency for all stakeholders involved," said
Elizabeth Morris, Senior Product
Manager at Suvoda.
Suvoda ePatient is expected to deliver four key
benefits.
- Faster Patient Payments: Streamlined patient
stipend and reimbursement payments with automated triggers,
reducing site burden and expediting the payment process for
patients.
- Improved Patient Experience: Centralized solution
that improves the patient experience and engagement bringing
together all necessary applications in one place and supporting
multiple payment methods.
- Reduced Workload on Sites and Sponsors: A single,
unified platform for Suvoda ePatient, eCOA, IRT, and eConsent
enables site users to seamlessly move between applications with
single sign-on and a single data layer minimizing data
reconciliation and decreasing the room for error.
- Enhanced Privacy and Security: A robust security
layer designed to ensure sensitive financial details remain
confidential and inaccessible to site users.
"Participating in a clinical trial is one of the most vulnerable
periods in a patient's life," said Jagath Wanninayake, CEO of
Suvoda. "We are committed to creating solutions that address the
urgent moments on a patient's journey. ePatient takes us a step
closer to achieving this mission."
Suvoda will take a phased approach to rolling out ePatient
starting with patient payments and followed by appointments and
reminders. The application will be available on both iOS and
Android devices. ePatient is available for a select group of early
adopters in June 2024 with general
availability expected in 2025.
About Suvoda
Suvoda is a global clinical trial technology company specializing
in complex, life-sustaining studies in therapeutic areas like
oncology, central nervous system (CNS), and rare diseases. Founded
in 2013 by experts in eClinical technologies, Suvoda empowers
clinical trial professionals to manage the most urgent moments in
the most urgent trials through advanced software solutions
delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in
Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo,
Japan. The company's Net Promoter Score (NPS) consistently
exceeds the technology industry average, contributing to the
company being selected by trial sponsors and CROs to support more
than 1,400 trials across 85 countries. To learn more,
visit suvoda.com. Follow Suvoda on LinkedIn.
Logo -
https://mma.prnewswire.com/media/1759317/4774510/Suvoda_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/suvoda-expands-its-clinical-trial-offering-with-the-introduction-of-epatient-302182292.html